Interstitial lung diseases in a lung cancer screening trial
نویسندگان
چکیده
منابع مشابه
Interstitial lung diseases in a lung cancer screening trial.
We assessed the prevalence of interstitial lung disease (ILD) in a cohort of smokers included in a lung cancer screening trial. Two observers independently reviewed, for the presence of findings consistent with ILD, the computed tomography (CT) examinations of 692 heavy smokers recruited by the Multicentric Italian Lung Detection (MILD) trial. Four CT patterns were considered: usual interstitia...
متن کاملInternational Congress of Airway & Interstitial Lung Diseases (ICAILD 2018)
“International Congress of Airway & Interstitial Lung Diseases” took place on November 14-16, 2018, in Pardisan Hotel,Mashhad,Iran. Hosted in our home city of Mashhad, the second largest city, in the North East of Iran. It is famous for the holy shrine of Imam Reza as well as Toos,the residence of Ferdowsi, the great Persian poet. The congress scientific program presented the best in science an...
متن کاملLung Cancer and Interstitial Lung Diseases: A Systematic Review
Interstitial lung diseases (ILDs) represent a heterogeneous group of more than two hundred diseases of either known or unknown etiology with different pathogenesis and prognosis. Lung cancer, which is the major cause of cancer death in the developed countries, is mainly attributed to cigarette smoking and exposure to inhaled carcinogens. Different studies suggest a link between ILDs and lung ca...
متن کاملOccupational Interstitial Lung Diseases.
OBJECTIVE Evidence-based diagnostic and treatment guidelines for occupationally related interstitial lung diseases (ILDs) have been developed and are summarized herein. METHODS Comprehensive literature reviews were conducted with article abstraction, critiquing, objective grading, and evidence table compilation. A multidisciplinary expert panel drafted evidence- and consensus-based guidance. ...
متن کاملLung Cancer Screening: Subsequent Evidences of National Lung Screening Trial
The US National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality and a 6.7% decrease in all-cause mortality. The NLST is the only trial showing positive results in a high-risk population, such as in patients with old age and heavy ever smokers. Lung cancer screening using a low-dose chest computed tomography might be beneficial for the high-risk group. However, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Journal
سال: 2011
ISSN: 0903-1936,1399-3003
DOI: 10.1183/09031936.00201809